Moderna’s potential COVID-19 vaccine rely on a technology called messenger RNA, which is designed to transform the body's own cells to making the vaccine
COVAXIN has been evaluated in about 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data
Dr Ravi Malik, a former secretary of Indian Medical Association (IMA), talked about increase in COVID-19 cases, carelessness creeping in and rise in pollution levels
A recent Harvard study has shown that people with COVID-19 who live in regions with high levels of air pollution are more likely to die from...
The COVID-19 related bio-medical waste generation in India has increased from 3,025.41 tonnes in June to 5,490 tonnes in September
During Diwali, not only COVID patients, but those with allergy, asthma, bronchitis, and even Chronic Obstructive Pulmonary Disease (COPD) should be careful as the bursting of...
Delhi Health Minister Satyendar Jain said that the Delhi government launched the Jeevan Seva app to facilitate COVID-19 patients in home isolation
Serum Institute of India said that it had enrolled 1,600 participants in India for the late-stage trials of AstraZeneca's candidate, and also plans to seek regulatory...
Psychologist Shweta Sharma said people have already reached a higher stage of fear and anxiety in the COVID-19 pandemic and this is the reason for their...
According to a health official of Delhi government, ICU facilities in the city are in such short supply that some hospitals are squeezing more beds for...
The promising results of the COVID-19 vaccine trials so far give confidence that Covishield could be a realistic solution to the deadly pandemic
Satyendar Jain asserted that the city government has significantly ramped up testing by nearly three times
